日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

α4β2尼古丁乙酰胆碱受体部分激动剂伐尼克兰、金雀花碱和二尼克兰的临床前特性可转化为治疗尼古丁依赖的临床疗效。

Rollema, H; Shrikhande, A; Ward, K M; Tingley, F D 3rd; Coe, J W; O'Neill, B T; Tseng, E; Wang, E Q; Mather, R J; Hurst, R S; Williams, K E; de Vries, M; Cremers, T; Bertrand, S; Bertrand, D

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors

CP-154,526:一种强效且选择性的非肽类促肾上腺皮质激素释放因子受体拮抗剂

Schulz, D W; Mansbach, R S; Sprouse, J; Braselton, J P; Collins, J; Corman, M; Dunaiskis, A; Faraci, S; Schmidt, A W; Seeger, T; Seymour, P; Tingley, F D 3rd; Winston, E N; Chen, Y L; Heym, J